We analyzed the expression patterns of MCM10 in relation to BC in patient cohorts by acquiring microarray gene expression data from the GENT2 database, in ex-vivo patients specimens having a different degree of BC malignancy and, in less aggressive and highly aggressive breast cancer cell lines. Here, MCM10 is linked to breast cancer.